Phase 3 biotech - USA Herald

Home Tags Phase 3 biotech

America

Generate Biomedicines Files for $400 Million IPO to Advance Long-Acting Antibody Candidate for Severe Asthma Unmet Need

Rachel Moore -

February 23, 2026

We are The People's Media. USA Herald covers everything from breaking news to investigative journalism. We also report on politics on the State and National levels.

Tag: Phase 3 biotech

Generate Biomedicines Files for $400 Million IPO to Advance Long-Acting Antibody Candidate for Severe Asthma Unmet Need